Lexington Medical, a US-based medical device company delivering minimally-invasive surgical stapling solutions has achieved over 10,000 successful surgeries with the AEON™ Endostapler in multiple countries.
“We are pleased to reach this exciting milestone for our AEON surgical stapling devices,” said Leon Amariglio, Founder and Chief Executive Officer, Lexington Medical. “As Lexington Medical is dedicated to providing surgeons with high quality stapling solutions, we look forward to further expanding our global reach and benefiting more patients across the world. We thank all of the surgeons and partners who have traveled this journey with us and helped achieve this significant milestone.”
The AEON Endostapler is clinically proven to deliver better staple formation as shown in tens of thousands of staple lines and uniquely addresses the challenges of variable tissue types in critical procedures including bariatric, thoracic, colorectal, and hepatobiliary surgeries.1 AEON has been adopted by key global opinion leaders as their preferred stapler for its excellent performance, surgical precision, and patented technologies including the advanced reload architecture, multi-speed firing gear, and smooth articulation.
Recent findings from a randomized clinical trial demonstrated that AEON produces a significantly drier staple line outperforming another surgical stapling device and is associated with a 20% reduction in interventional bleeding control.2 In this peer-reviewed, blinded study the investigators also reported consistent satisfaction with AEON staple lines.
To learn more, visit www.lexington-med.com.